Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

682
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
682
Positron Emission Tomography01:29

Positron Emission Tomography

7.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
7.9K
Applications Of NMR In Biology01:25

Applications Of NMR In Biology

4.6K
Nuclear magnetic resonance (NMR) spectroscopy is a very valuable analytical technique for researchers. It has been used for more than 50 years as an analytical tool. F. Bloch and E. Purcell formulated NMR in 1946 and won the 1952 Nobel Prize in Physics  for their work. Biological macromolecules such as proteins, nucleic acids, lipids, and organic molecules including pharmaceutical compounds, can be studied using this versatile tool that exploits the magnetic properties of certain nuclei.
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune dysregulation in the prostates of C57BL/6<sup>Aire-/-</sup> mice mirrors that seen in human benign prostatic hyperplasia.

The Journal of pathology·2026
Same author

WDR82 suppresses breast cancer progression by inhibiting ERK-driven chemokine expression and neutrophil infiltration.

International journal of biological sciences·2026
Same author

Prevalence of Gastroesophageal reflux disease in patients with Idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

BMC pulmonary medicine·2026
Same author

Machine Learning-Enhanced SERS Sensor Using Microgroove Structures for Enriching and Confining Nanoplastics in Localized 3D Hotspots.

Analytical chemistry·2026
Same author

Improving catalytic aquathermolysis of heavy oil using a tri-metal supported zeolite catalyst.

RSC advances·2026
Same author

Arginine restriction exploits DNMT3B-ASS1-driven arginine auxotrophy and mTORC1-suppressed autophagy to overcome niraparib resistance in ovarian cancer.

Cancer letters·2026

Related Experiment Video

Updated: Mar 5, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

10.9K

Molecular Imaging in Nanotechnology and Theranostics.

Chrysafis Andreou1, Suchetan Pal1, Lara Rotter2

  • 1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.

Molecular Imaging and Biology
|March 29, 2017
PubMed
Summary

The Molecular Imaging in Nanotechnology and Theranostics (MINT) group fosters collaboration in nanomedicine and theranostics. This review highlights recent nanoconstructs for potential clinical translation.

Keywords:
ImagingMINTNanoparticlesTheranosticWMIS

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.5K
Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
08:09

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

12.2K

Related Experiment Videos

Last Updated: Mar 5, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

10.9K
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.5K
Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
08:09

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

12.2K

Area of Science:

  • Biomedical Nanotechnology
  • Theranostics
  • Molecular Imaging

Background:

  • Exponential growth in biomedical nanotechnology and theranostics fields.
  • Establishment of the Molecular Imaging in Nanotechnology and Theranostics (MINT) Interest Group within the World Molecular Imaging Society (WMIS) in 2015.
  • MINT aims to unify scientists working on molecular imaging with nanotechnology and theranostic agents.

Purpose of the Study:

  • To provide a condensed overview of key areas covered by the MINT Interest Group.
  • To focus on recent developments (last 3-5 years) in nanoconstructs for theranostics and molecular imaging.
  • To offer insight into emerging technologies with potential for near-future clinical translation.

Main Methods:

  • Review of recent scientific literature and MINT activities.
  • Focus on nanoconstructs within the broader field of theranostics.
  • Analysis of developments from the past 3-5 years.

Main Results:

  • The MINT group represents diverse scientific expertise in nanotechnology and theranostics.
  • Key areas covered include advanced nanoconstructs for molecular imaging and therapy.
  • Emerging technologies show promise for clinical applications.

Conclusions:

  • The MINT Interest Group serves as a crucial forum for advancing nanomedicine and theranostics.
  • Recent nanoconstruct developments are paving the way for innovative clinical solutions.
  • Continued research in this interdisciplinary field holds significant potential for future medical breakthroughs.